These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 19812412)

  • 1. Rates of serious infection after medical abortion.
    Kapp N; Winikoff B; Blumenthal PD
    N Engl J Med; 2009 Oct; 361(15):1511-2; author reply 1512. PubMed ID: 19812412
    [No Abstract]   [Full Text] [Related]  

  • 2. Rates of serious infection after changes in regimens for medical abortion.
    Fjerstad M; Trussell J; Sivin I; Lichtenberg ES; Cullins V
    N Engl J Med; 2009 Jul; 361(2):145-51. PubMed ID: 19587339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing vaginal and buccal misoprostol when used after methotrexate for early abortion.
    Wiebe ER; Trouton K
    Contraception; 2004 Dec; 70(6):463-6. PubMed ID: 15541407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
    Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
    Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medical abortion using methotrexate and misoprostol. Efficacy and tolerability].
    Iamakov K; Pekhlivanov B; Amaliev I
    Akush Ginekol (Sofiia); 2005; 44(3):16-8. PubMed ID: 16028385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of infection following the introduction of new infection control measures for medical abortion.
    Fjerstad M; Trussell J; Lichtenberg ES; Sivin I; Cullins V
    Contraception; 2011 Apr; 83(4):330-5. PubMed ID: 21397090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of laminaria, oral misoprostol, and vaginal misoprostol before abortion.
    Sperling AL
    Obstet Gynecol; 1999 Oct; 94(4):637. PubMed ID: 10511374
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion.
    Tang OS; Ho PC
    Contraception; 2006 Jul; 74(1):26-30. PubMed ID: 16781256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misoprostol administered by epithelial routes: Drug absorption and uterine response.
    Meckstroth KR; Whitaker AK; Bertisch S; Goldberg AB; Darney PD
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):582-90. PubMed ID: 16946218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can vaginal misoprostol be administered 1 to 3 days after mifepristone without loss of efficacy or an increase in adverse events?
    Richardson CR
    J Fam Pract; 2001 Jan; 50(1):9. PubMed ID: 11195490
    [No Abstract]   [Full Text] [Related]  

  • 12. Concurrent use of mifepristone and misoprostol for early medical abortion.
    Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion.
    Ellis SC; Kapp N; Vragpvoc O; Borgata L
    Contraception; 2010 May; 81(5):441-5. PubMed ID: 20399952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of intravenous oxytocin to vaginal misoprostol for mid trimester labor induction.
    Hidar S; Jerbi M; Khaïri H
    Am J Obstet Gynecol; 2006 Jul; 195(1):332-3; author reply 333-4. PubMed ID: 16813766
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of mifepristone and sublingual misoprostol for early medical abortion.
    Lin M; Li YT; Chen FM; Wu SF; Tsai CW; Chen TH; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):321-4. PubMed ID: 17175490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone vaginally in an early medical abortion regimen: a pilot study.
    Sharma S; El-Refaey H; Mitchel H; Ozturk O; Rodeck C
    Contraception; 2006 Mar; 73(3):261-4. PubMed ID: 16472567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks.
    Bhattacharjee N; Saha SP; Ghoshroy SC; Bhowmik S; Barui G
    Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):165-71. PubMed ID: 18366490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
    Kapp N; Borgatta L; Ellis SC; Stubblefield P
    Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions.
    Aldrich T; Winikoff B
    BJOG; 2007 May; 114(5):555-62. PubMed ID: 17439563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in infection-related mortality since modifications in the regimen of medical abortion.
    Trussell J; Nucatola D; Fjerstad M; Lichtenberg ES
    Contraception; 2014 Mar; 89(3):193-6. PubMed ID: 24405798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.